Key developments in biotech news include the promising results of a gene therapy for deafness, which is showing real-world benefits. There are growing concerns about the impact of ultra-cheap telehealth options on patient care, particularly regarding access to prescription drugs. Additionally, Robert F. Kennedy Jr. has adjusted his stance on vaccines during recent congressional hearings, signaling potential shifts in his approach. Meanwhile, Sanofi’s research focus may be shifting under new CEO Belén Garijo, especially after mixed results in their immunology projects.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.statnews.com/2026/04/23/biotech-news-sanofi-research-priorities-in-flux-with-new-ceo/
